915
Views
4
CrossRef citations to date
0
Altmetric
Perspectives in Rehabilitation

Integrative intervention: a new perspective and brief review in aphasia

&
Pages 1999-2009 | Received 16 Dec 2015, Accepted 09 Jul 2016, Published online: 27 Aug 2016

References

  • Brady MC, Kelly H, Godwin J, et al. Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev. 2012; Issue 5. Art. No.: CD000425. doi:10.1002/14651858.CD000425.pub3.
  • Berthier ML, Pulvermüller F. Neuroscience insights improve neurorehabilitation of poststroke aphasia. Nat Rev Neurol. 2011;7:86–97.
  • Meinzer M, Djundja D, Barthel G, et al. Long-term stability of improved language functions in chronic aphasia after constraint-induced aphasia therapy. Stroke. 2005;36:1462–1466.
  • Maher LM, Kendall D, Swearengin JA, et al. A pilot study of use-dependent learning in the context of Constraint Induced Language Therapy. J Int Neuropsychol Soc. 2006;12:843–852.
  • Szaflarski JP, Ball AL, Grether S, et al. Constraint-induced aphasia therapy stimulates language recovery in patients with chronic aphasia after ischemic stroke. Med Sci Monit. 2008;14:CR243.
  • Rochon E, Leonard C, Burianova H, et al. Neural changes after phonological treatment for anomia: an fMRI study. Brain Lang. 2010;114:164–179.
  • Baker JM, Rorden C, Fridriksson J. Using transcranial direct-current stimulation to treat stroke patients with aphasia. Stroke. 2010;41:1229–1236.
  • Harnish SM, Neils-Strunjas J, Lamy M, et al. Use of fMRI in the study of chronic aphasia recovery after therapy: a case study. Top Stroke Rehabilit. 2008;15:468–483.
  • Pulvermüller F, Neininger B, Elbert T, et al. Constraint-induced therapy of chronic aphasia after stroke. Stroke. 2001;32:1621–1626.
  • Small SL. The future of aphasia treatment. Brain Lang. 2000;71:227–232.
  • Use of Complementary Health Approaches in the U.S. 2016. Available from: https://www.nih.gov/news-events/americans-spent-302-billion-out-pocket-complementary-health-approaches.
  • Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation. 2015;131:e29.
  • Aftonomos LB, Steele RD, Appelbaum JS, et al. Relationships between impairment-level assessments and functional-level assessments in aphasia: findings from LCC treatment programmes. Aphasiology. 2001;15:951–964.
  • Quinn TJ, Paolucci S, Sunnerhagen KS, et al. Evidence-based stroke rehabilitation: an expanded guidance document from the European Stroke Organisation (ESO) guidelines for management of ischaemic stroke and transient ischaemic attack 2008. J Rehabilit Med. 2009;41:99–111.
  • Bell IR, Caspi O, Schwartz GE, et al. Integrative medicine and systemic outcomes research: issues in the emergence of a new model for primary health care. Arch Intern Med. 2002;162:133–140.
  • Laures JS, Shisler RJ. Complementary and alternative medical approaches to treating adult neurogenic communication disorders: a review. Disabil Rehabilit. 2004;26:315–325.
  • Marshall RS, Laures-Gore J. CE introduction: what is complementary and alternative medicine? SIG 2 Perspect Neurophysiol Neurogen Speech Lang Disord. 2008;18:86–89.
  • Laures-Gore JS, Marshall RS. Acupuncture as a treatment technique for aphasia and cognitive impairments. SIG 2 Perspect Neurophysiol Neurogen Speech Lang Disord. 2008;18:107–113.
  • Majid A. Neuroprotection in stroke: past, present, and future. ISRN Neurol. 2014;2014 Article ID: 515716, 17 pages.
  • Chen S-D, Yang D-I, Lin T-K, et al. Roles of oxidative stress, apoptosis, PGC-1α and mitochondrial biogenesis in cerebral ischemia. Int J Mol Sci. 2011;12:7199–7215.
  • St-Pierre J, Drori S, Uldry M, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006;127:397–408.
  • Chen S-D, Chang AY, Chuang Y-C. The potential role of mitochondrial dysfunction in seizure-associated cell death in the hippocampus and epileptogenesis. J Bioenerg Biomembr. 2010;42:461–465.
  • Yan F, Hu Q, Chen J, et al. Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett. 2013;543:163–167.
  • Lapolt PS, Yu SM, Lu J. Early treatment of young female rats with progesterone delays the aging-associated reproductive decline: a counteraction by estradiol. Biol Reprod. 1988;38:987–995.
  • Mann G, Lamming G. The influence of progesterone during early pregnancy in cattle. Reprod Domest Anim. 1999;34:269–274.
  • Pincus G. Some effects of progesterone and related compounds upon reproduction and early development in mammals. Acta Endocrinol. 1956;23(4 Suppl):S18–S36.
  • Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs. 2010;19:847–857.
  • Stein DG. Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience. 2011;191:101–106.
  • Stein DG, Hoffman SW. Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries. Pediatr Rehabil. 2003;6:13–22.
  • Shear DA, Galani R, Hoffman SW, et al. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol. 2002;178:59–67.
  • Sayeed I, Stein DG. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res. 2009;175:219–237.
  • Roof RL, Hall ED. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma. 2000;17:367–388.
  • Slemmer JE, Shacka JJ, Sweeney M, et al. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem. 2008;15:404–414.
  • Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med. 1999;222:236–245.
  • Loren DJ, Seeram NP, Schulman RN, et al. Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Pediatr Res. 2005;57:858–864.
  • Sweeney MI. Pomegranate juice consumption reduces simulated ischemic stroke damage and increases brain antioxidant status in rats. In: Seeram N, Schulman R, Heber D, editors. Pomegranate: ancient roots to modern medicine. CRC Press; 2006, p. 91–106.
  • West T, Atzeva M, Holtzman DM. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci. 2007;29:363–372.
  • Zhuang H, Kim YS, Koehler RC, et al. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann N Y Acad Sci. 2003;993:276–286.
  • Frankel E, Waterhouse A, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993;341:1103–1104.
  • Ahmad A, Khan MM, Raza SS, et al. Ocimum sanctum attenuates oxidative damage and neurological deficits following focal cerebral ischemia/reperfusion injury in rats. Neurol Sci. 2012;33:1239–1247.
  • Kaur G, Bali A, Singh N, et al. Ameliorative potential of Ocimum sanctum in chronic constriction injury-induced neuropathic pain in rats. Anais Acad Brasil Ciênc. 2015;87:417–429.
  • Yanpallewar S, Rai S, Kumar M, et al. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacol Biochem Behav. 2004;79:155–164.
  • Devi PU. Radioprotective, anticarcinogenic and antioxidant properties of the Indian holy basil, Ocimum sanctum (Tulasi). Indian J Exp Biol. 2001;39:185–190.
  • Sen P, Maiti P, Puri S, et al. Mechanism of anti-stress activity of Ocimum sanctum Linn, eugenol and Tinospora malabarica in experimental animals. Indian J Exp Biol. 1992;30:592–596.
  • Laures-Gore JS, DuBay MF, Duff MC, et al. Identifying behavioral measures of stress in individuals with aphasia. J Speech Lang Hear Res. 2010;53:1394–1400.
  • Smith S. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience. 1991;42:309–320.
  • Pettus EH, Wright DW, Stein DG, et al. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res. 2005;1049:112–119.
  • Cutler SM, Cekic M, Miller DM, et al. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma. 2007;24:1475–1486.
  • Roof RL, Duvdevani R, Braswell L, et al. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol. 1994;129:64–69.
  • Skolnick BE, Maas AI, Narayan RK, et al. A clinical trial of progesterone for severe traumatic brain injury. N Engl J Med. 2014;371:2467–2476.
  • Cekic M, Sayeed I, Stein DG. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol. 2009;30:158–172.
  • Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol. 2009;30:142–157.
  • Gold SM, Voskuhl RR. Estrogen treatment in multiple sclerosis. J Neurol Sci. 2009;286:99–103.
  • Suzuki S, Brown CM, Wise PM. Neuroprotective effects of estrogens following ischemic stroke. Front Neuroendocrinol. 2009;30:201–211.
  • Pike CJ, Carroll JC, Rosario ER, et al. Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol. 2009;30:239–258.
  • Dubal DB, Kashon ML, Pettigrew LC, et al. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab. 1998;18:1253–1258.
  • Robinson D, Friedman L, Marcus R, et al. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc. 1994;42:919–922.
  • Yaffe K, Sawaya G, Lieberburg I, et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279:688–695.
  • Kampen DL, Sherwin BB. Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol. 1994;83:979.
  • Fisher M, Lees K, Spence JD. Nutrition and stroke prevention. Stroke. 2006;37:2430–2435.
  • Ray S, Rana P, Rajput M, et al. Nutritional management of stroke: from current evidence to conjecture. Nutr Bull. 2007;32:145–153.
  • Davis JP, Wong AA, Schluter PJ, et al. Impact of premorbid undernutrition on outcome in stroke patients. Stroke. 2004;35:1930–1934.
  • Dávalos A, Ricart W, Gonzalez-Huix F, et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke. 1996;27:1028–1032.
  • Stechmiller JK. Early nutritional screening of older adults: review of nutritional support. J Infus Nurs. 2003;26:170–177.
  • Ortega RM, Requejo AM, Andres P, et al. Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr. 1997;66:803–809.
  • La RA, Koehler KM, Wayne SJ, et al. Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr. 1997;65:20–29.
  • Bourre J-M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006;10:377.
  • Malouf R, Grimley Evans J, Areosa Sastre A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;Issue 4. Art. No.: CD004514. doi:10.1002/14651858.CD004514.
  • Amarantos E, Martinez A, Dwyer J. Nutrition and quality of life in older adults. J Gerontol A: Biol Sci Med Sci. 2001;56:54–64.
  • Gómez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci. 2008;9:568–578.
  • Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J Neural Transm (Vienna). 2003;110:95–110.
  • Leigh Gibson E, Green MW. Nutritional influences on cognitive function: mechanisms of susceptibility. Nutr Res Rev. 2002;15:169–206.
  • Jama JW, Launer LJ, Witteman J, et al. Dietary antioxidants and cognitive function in a population-based sample of older persons: the Rotterdam study. Am J Epidemiol. 1996;144:275–280.
  • Bayer-Carter JL, Green PS, Montine TJ, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011;68:743–752.
  • Neuhouser ML, Schwarz Y, Wang C, et al. A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr. 2012;142:369–374.
  • Teunissen C, De Vente J, Von Bergmann K, et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol Aging. 2003;24:147–155.
  • Schram MT, Trompet S, Kamper AM, et al. Serum calcium and cognitive function in old age. J Am Geriatr Soc. 2007;55:1786–1792.
  • Alley DE, Crimmins EM, Karlamangla A, et al. Inflammation and rate of cognitive change in high-functioning older adults. J Gerontol A Biol Sci Med Sci. 2008;63:50–55.
  • Chiu C-C, Su K-P, Cheng T-C, et al. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1538–1544.
  • Mazza M, Pomponi M, Janiri L, et al. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:12–26.
  • Cole GM, Ma Q-L, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids. 2009;81:213–221.
  • Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Intervent Aging. 2010;5:45.
  • Palacios-Pelaez R, Lukiw WJ, Bazan NG. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol. 2010;41:367–374.
  • Yehuda S, Rabinovtz S, Carasso RL, et al. Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci. 1996;87:141–149.
  • Otsuka M. Analysis of dietary factors in Alzheimer's disease: clinical use of nutritional intervention for prevention and treatment of dementia. Nihon Ronen Igakkai Zasshi. Japan J Geriatr. 2000;37:970–973.
  • Hashimoto M, Hossain S, Agdul H, et al. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid β-infused rats relates to the decreases of amyloid β and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta (BBA)-Mol Cell Biol Lipids. 2005;1738:91–98.
  • Song C, Horrobin D. Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. J Lipid Res. 2004;45:1112–1121.
  • Wu A, Ying Z, Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma. 2004;21:1457–1467.
  • Hu FB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003;78:544S–551S.
  • Barnard ND, Cohen J, Jenkins DJ, et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care. 2006;29:1777–1783.
  • Craig WJ, Mangels AR. Position of the American Dietetic Association: vegetarian diets. J Am Dietet Assoc. 2009;109:1266–1282.
  • Chainani-Wu N, Weidner G, Purnell DM, et al. Changes in emerging cardiac biomarkers after an intensive lifestyle intervention. Am J Cardiol. 2011;108:498–507.
  • Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
  • Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2.
  • Fang Y-Z, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18:872–879.
  • Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12:274–277.
  • Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J. 1987;1:441–445.
  • Kehrer JP. Free radicals as mediators of tissue injury and disease. CRC Crit Rev Toxicol. 1993;23:21–48.
  • Guarner F, Malagelada J-R. Gut flora in health and disease. Lancet. 2003;361:512–519.
  • Salminen S, Bouley C, Boutron M-C, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80:S147–S171.
  • Duggan C, Gannon J, Walker WA. Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr. 2002;75:789–808.
  • Astrup A, Dyerberg J, Selleck M, et al. Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes Rev. 2008;9:48–52.
  • Ferrari C, Torres E. Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed Pharmacother. 2003;57:251–260.
  • Jabs J, Devine CM. Time scarcity and food choices: an overview. Appetite. 2006;47:196–204.
  • Health UDo, Services. Healthy people 2000: National Health Promotion and Disease Prevention Objectives-Nutrition Priority Area. Nutr Today. 1990;25:29–39.
  • Topping DL, Fukushima M, Bird AR. Resistant starch as a prebiotic and synbiotic: state of the art. Proc Nutr Soc. 2003;62:171–176.
  • Tungland B, Meyer D. Nondigestible oligo‐ and polysaccharides (dietary fiber): their physiology and role in human health and food. Comprehens Rev Food Sci Food Saf. 2002;1:90–109.
  • de Felippe JJ, Maciel F, Soares AM, et al. Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). Surg Gynecol Obstetr. 1993;177:383–388.
  • Bengmark S. Integrative medicine and human health-the role of pre-, pro- and synbiotics. Clin Transl Med. 2012;1:1–13.
  • Tucker KL, Hannan MT, Chen H, et al. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999;69:727–736.
  • Tucker KL, Chen H, Hannan MT, et al. Bone mineral density and dietary patterns in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr. 2002;76:245–252.
  • Liu Q, Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441–1449.
  • Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5–16.
  • Tomporowski PD. Men's and women's perceptions of effort during progressive-resistance strength training. Percept Motor Skills. 2001;92:368–372.
  • Quaney BM, Boyd LA, McDowd JM, et al. Aerobic exercise improves cognition and motor function poststroke. Neurorehabilit Neural Repair. 2009;23:879–885.
  • Vaynman S, Ying Z, Gomez‐Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci. 2004;20:2580–2590.
  • Colcombe Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14:125–130.
  • Colcombe SJ, Kramer AF, Erickson KI, et al. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci USA. 2004;101:3316–3321.
  • Smith MA, Hii HL, Foster JK, et al. Glucose enhancement of memory is modulated by trait anxiety in healthy adolescent males. J Psychopharmacol (Oxford). 2011;25:60–70.
  • Chapman SB, Aslan S, Spence JS, et al. Shorter term aerobic exercise improves brain, cognition, and cardiovascular fitness in aging. Front Aging Neurosci. 2013;5:75.
  • McGregor KM, Nocera JR, Sudhyadhom A, et al. Effects of aerobic fitness on aging-related changes of interhemispheric inhibition and motor performance. Front Aging Neurosci. 2013;5:66. doi:10.3389/fnagi.2013.00066.
  • Rosano C, Venkatraman VK, Guralnik J, et al. Psychomotor speed and functional brain MRI 2 years after completing a physical activity treatment. J Gerontol A: Biol Sci Med Sci. 2010;65:639–647.
  • Voss MW, Erickson KI, Prakash RS, et al. Functional connectivity: a source of variance in the association between cardiorespiratory fitness and cognition? Neuropsychologia. 2010;48:1394–1406.
  • Amoyal N, Fallon E. Physical exercise and cognitive training clinical interventions used in slowing degeneration associated with mild cognitive impairment: a review of the recent literature. Top Geriatr Rehabilit. 2012;28:208–216.
  • Lorenzen B, Murray L, Lorenzen-Huber L, et al. Physical fitness training for persons with aphasia. Poster Session Presented at the Annual American Speech Language and Hearing Association; 2010; Philadelphia, PA.
  • Harnish SM. Aerobic exercise as an adjuvant to aphasia therapy: preliminary data. Paper presented at: the Annual Convention of the American Speech-Language-Hearing Association; Atlanta; GA 2012.
  • Williams JMG, Teasdale JD, Segal ZV, et al. The mindful way through depression: freeing yourself from chronic unhappiness. New York: Guilford Press; 2007.
  • Douglass L. Yoga as an intervention in the treatment of eating disorders: does it help? Eat Disord. 2009;17:126–139.
  • Singh Malhotra V, Singh K, et al. Role of yoga in modifying certain cardiovascular functions in type-2 diabetic patients. J Assoc Phys India. 2004;52:203–206.
  • Gangadhar B, Varambally S. Yoga as therapy in psychiatric disorders: past, present, and future. Biofeedback. 2011;39:60–63.
  • Sullivan MC, Elena Manning B, Bannuru R. Yoga for rheumatic conditions: potential physical, cognitive and affective advantages. J Yoga Phys Ther. 2014;4:2.
  • Sathyaprabha T, Satishchandra P, Pradhan C, et al. Modulation of cardiac autonomic balance with adjuvant yoga therapy in patients with refractory epilepsy. Epilepsy Behav. 2008;12:245–252.
  • Lynton H, Kligler B, Shiflett S. Yoga in stroke rehabilitation: a systematic review and results of a pilot study. Top Stroke Rehabilit. 2007;14:1–8.
  • Bastille JV, Gill-Body KM. A yoga-based exercise program for people with chronic poststroke hemiparesis. Phys Ther. 2004;84:33–48.
  • Lazaridou A, Philbrook P, Tzika AA. Yoga and mindfulness as therapeutic interventions for stroke rehabilitation: a systematic review. Evid-Based Complement Altern Med. 2013;2013:Article ID 357108, 9 pages. doi:10.1155/2013/357108.
  • Schmid AA, Van Puymbroeck M, Altenburger PA, et al. Balance and balance self-efficacy are associated with activity and participation after stroke: a cross-sectional study in people with chronic stroke. Arch Phys Med Rehabilit. 2012;93:1101–1107.
  • Garrett R, Immink MA, Hillier S. Becoming connected: the lived experience of yoga participation after stroke. Disabil Rehabilit. 2011;33:2404–2415.
  • Gothe N, Pontifex MB, Hillman C, et al. The acute effects of yoga on executive function. J Phys Act Health. 2013;10:488–495.
  • Subramanya P, Telles S. Effect of two yoga-based relaxation techniques on memory scores and state anxiety. Biopsychosoc Med. 2009;3:8. doi:10.1186/1751-0759-3-8.
  • Papp ME, Lindfors P, Storck N, et al. Increased heart rate variability but no effect on blood pressure from 8 weeks of hatha yoga – a pilot study. BMC Res Notes. 2013;6:59.
  • Streeter C, Gerbarg P, Saper R, et al. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypoth. 2012;78:571–579.
  • Malathi A, Parulkar VG. Effect of yogasanas on the visual and auditory reaction time. Indian J Physiol Pharmacol. 1989;33:110–112.
  • Goodglass H, Kaplan E, Barresi B. Boston Diagnostic Aphasia Examination-(BDAE-3). San Antonio (TX): Psychological Corporation; 2000.
  • Hines M, O'Connor J. A measure of finger dexterity. J Person Res. 1926;4:379–382.
  • Mohapatra B, Marshall RS, Laures-Gore J. Yogic breathing and ayurveda in aphasia: a case study. Top Stroke Rehabilit. 2014;21:272–280.
  • Satchidananda S. The yoga sutras of Patanjali: commentary on the raja yoga sutras by Sri Swami Satchidananda. Yogaville (VA): Integral Yoga Publications; 1990. p. 252.
  • Kertesz A. Western Aphasia Battery-Revised (WAB-R). San Antonio: Pearson; 2006.
  • Conners C, Staff M. Conners’ continuous performance test II: computer program for Windows technical guide and software manual. North Tonwanda (NY): Multi-Health Systems; 2000.
  • D’Elia L, Satz P, Uchiyama C, et al. Color trails test manual. Odessa (FL): Psychological Assessment Resources; 1997.
  • Beck Steer RA. BAI, Beck anxiety inventory. San Antonio (TX): Psychological Corporation; 1990.
  • Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
  • Yesavage JA, Sheikh JI. 9/Geriatric Depression Scale (GDS) recent evidence and development of a shorter violence. Clin Gerontol. 1986;5:165–173.
  • Marshall RS, Basilakos A, Williams T, et al. Exploring the benefits of unilateral nostril breathing practice post-stroke: attention, language, spatial abilities, depression, and anxiety. J Altern Complement Med. 2014;20:185–194.
  • Ristuccia C, Ristuccia J. Yogic techniques in therapy. Adv Health Care Netw Speech Hear. 2010;20:12.
  • Koziol LF, Budding D, Andreasen N, et al. Consensus paper: the cerebellum's role in movement and cognition. Cerebellum. 2014;13:151–177.
  • Moore A, Malinowski P. Meditation, mindfulness and cognitive flexibility. Conscious Cognit. 2009;18:176–186.
  • Valentine ER, Sweet PL. Meditation and attention: a comparison of the effects of concentrative and mindfulness meditation on sustained attention. Ment Health Relig Cult. 1999;2:59–70.
  • Lazar SW, Kerr CE, Wasserman RH, et al. Meditation experience is associated with increased cortical thickness. Neuroreport. 2005;16:1893.
  • Tang Y-Y, Ma Y, Wang J, et al. Short-term meditation training improves attention and self-regulation. Proc Natl Acad Sci USA. 2007;104:17152–17156.
  • Jha AP, Krompinger J, Baime MJ. Mindfulness training modifies subsystems of attention. Cogn Affect Behav Neurosci. 2007;7:109–119.
  • Lavretsky H, Epel E, Siddarth P, et al. A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity. Int J Geriatr Psychiatry. 2013;28:57–65.
  • Leach MJ, Francis A, Ziaian T. Improving the health and well-being of community-dwelling caregivers of dementia sufferers: study protocol of a randomized controlled trial of structured meditation training. J Altern Complement Med. 2014;20:136–141.
  • Bédard M, Felteau M, Mazmanian D, et al. Pilot evaluation of a mindfulness-based intervention to improve quality of life among individuals who sustained traumatic brain injuries. Disabil Rehabil. 2003;25:722–731.
  • Bedard M, Felteau M, Gibbons C, et al. A mindfulness-based intervention to improve quality of life among individuals who sustained traumatic brain injuries: one-year follow-up. J Cognit Rehabilit. 2005;23:8–13.
  • Innes K, Selfe T, Brown C, et al. The Effects of meditation on perceived stress and related indices of psychological status and sympathetic activation in persons with Alzheimer's disease and their caregivers: a pilot study. Evid-Based Complement Altern Med. 2012;2012:Article ID 927509, 9 pages. doi:10.1155/2012/927509.
  • Ramel W, Goldin PR, Carmona PE, et al. The effects of mindfulness meditation on cognitive processes and affect in patients with past depression. Cognit Ther Res. 2004;28:433–455.
  • Rosenkranz MA, Davidson RJ, MacCoon DG, et al. A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav Immun. 2013;27:174–184.
  • Barak Y. The immune system and happiness. Autoimmun Rev. 2006;5:523–527.
  • Singh S. Positive psychological factors and immune functioning. In: Singh R, Shyam R, Singh S, editors. Psychoneuroimmunology: a behavioural approach. New Delhi, India: Global Vision Pub House; 2009. 243 p.
  • Shepherd J. Happiness and health: associations with cardiovascular disease risk factors. [Doctoral dissertation]. Auckland University of Technology; 2011.
  • Farrelly C. 'Positive biology' as a new paradigm for the medical sciences. Focusing on people who live long, happy, healthy lives might hold the key to improving human well-being. EMBO Rep. 2012;13:186–188.
  • Dillon KM, Minchoff B, Baker KH. Positive emotional states and enhancement of the immune system. Int J Psychiatry Med. 1985;15:13–18.
  • Pressman SD, Cohen S. Does positive affect influence health? Psychol Bull. 2005;131:925.
  • Code C, Herrmann M. The relevance of emotional and psychosocial factors in aphasia to rehabilitation. Neuropsychol Rehabil. 2003;13:109–132.
  • Salovey P, Rothman AJ, Detweiler JB, et al. Emotional states and physical health. Am Psychol. 2000;55:110.
  • Cohen S, Pressman SD. Positive affect and health. Curr Direct Psychol Sci. 2006;15:122–125.
  • Galantino ML, Baime M, Maguire M, et al. Association of psychological and physiological measures of stress in health‐care professionals during an 8‐week mindfulness meditation program: mindfulness in practice. Stress Health. 2005;21:255–261.
  • Chiesa A, Serretti A. A systematic review of neurobiological and clinical features of mindfulness meditations. Psychol Med. 2010;40:1239–1252.
  • Laures-Gore J, Marshall RS. Mindfulness meditation in aphasia: a case report. NeuroRehabilitation. 2016;38:321–329.
  • Orenstein E, Basilakos A, Marshall RS. Effects of mindfulness meditation on three individuals with aphasia. Int J Lang Commun Disord. 2012;47:673–684.
  • Laures-Gore J, Hamilton A, Matheny K. Coping resources, perceived stress, and recent life experiences in individuals with aphasia. J Med Speech-Lang Pathol. 2007;15:423–432.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.